Cost-effectiveness of ensuring hepatitis B protection for previously vaccinated healthcare personnel.

about

Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices.

P2860

Q55316446-4C848002-F120-4AB0-BE04-11D62CC5273C

P2860

Cost-effectiveness of ensuring hepatitis B protection for previously vaccinated healthcare personnel.

Item

http://www.wikidata.org/entity/Q42211174

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Cost-effectiveness of ensuring ...... ccinated healthcare personnel.

@en

Cost-effectiveness of ensuring ...... ccinated healthcare personnel.

@nl

type

Item

label

Cost-effectiveness of ensuring ...... ccinated healthcare personnel.

@en

Cost-effectiveness of ensuring ...... ccinated healthcare personnel.

@nl

prefLabel

Cost-effectiveness of ensuring ...... ccinated healthcare personnel.

@en

Cost-effectiveness of ensuring ...... ccinated healthcare personnel.

@nl

P1476

Cost-effectiveness of ensuring ...... ccinated healthcare personnel.

@en

P2093

Christina Bradley

http://www.w3.org/2001/XMLSchema#string

Meredith Reilly

http://www.w3.org/2001/XMLSchema#string

Sarah F Schillie

http://www.w3.org/2001/XMLSchema#string

Thomas J Hoerger

http://www.w3.org/2001/XMLSchema#string

Trudy V Murphy

http://www.w3.org/2001/XMLSchema#string

P2860

Risk and management of blood-borne infections in health care workers.

Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region

Economic analysis of promotion of hepatitis B vaccinations among Vietnamese-American children and adolescents in Houston and Dallas.

Immunity to hepatitis B virus (HBV) infection two decades after implementation of universal infant HBV vaccination: association of detectable residual antibodies and response to a single HBV challenge dose

Underreporting of blood and body fluid exposures among health care students and trainees in the acute care setting: a 2007 survey.

Seroprotection after recombinant hepatitis B vaccination among newborn infants: a review.

Hepatitis B: a case for prenatal screening of all patients.

Should all pregnant women be screened for hepatitis B?

The need for more aggressive follow-up of children born to hepatitis B surface antigen-positive mothers: lessons from the Louisiana Perinatal Hepatitis B Immunization Program.

Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers.

P304

845-854

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/676865

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24915213

http://www.w3.org/2001/XMLSchema#string

Cost-effectiveness of ensuring hepatitis B protection for previously vaccinated healthcare personnel.

about

P2860

P2860

Cost-effectiveness of ensuring hepatitis B protection for previously vaccinated healthcare personnel.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698